Cécilia Dallavalle

Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer.

S. Rossi, Jonathan Hall, Martina Roos, 2016, Cancer research.

A novel oncogenic axis involving the ETS factor ESE3/EHF, miR-424, COP1 and STAT3 drives prostate tumor progression

Cécilia Dallavalle, 2016 .

EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB

C. Catapano, N. Longoni, D. Albino, 2016, Molecular Cancer Therapeutics.

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.

S. Rossi, P. Ostano, A. Zitella, 2016, The Journal of clinical investigation.